Research Protocols

How It Works

BPC-157 (Body Protection Compound) is a 15-amino acid peptide derived from a gastric protective protein. It upregulates growth hormone receptor expression, accelerates angiogenesis (new blood vessel formation), and reduces inflammatory cytokines. TB-500 (Thymosin Beta-4) promotes actin polymerisation in damaged cells, accelerates migration of endothelial and keratinocyte cells, and reduces fibrosis. Together they address repair from two distinct mechanisms — making them highly synergistic for tendons, ligaments, muscle and joint tissue.

Research Protocol

Timeline of Effects

Biomarkers to Monitor

How It Works

The GLOW stack builds on Wolverine by adding GHK-Cu (Glycine-Histidine-Lysine-Copper), a naturally occurring copper peptide with profound collagen-stimulating properties. GHK-Cu upregulates collagen I, III, and IV synthesis, increases dermal thickness, activates antioxidant genes (via NRF2 pathway), and has been shown in research to reset the activity of 4,000+ genes toward a younger expression profile. Combined with BPC-157 and TB-500, this creates a complete tissue rebuilding system — inside and out. Ideal for aesthetics-conscious researchers seeking skin tightening, hair density, and structural joint improvements alongside functional repair.

Research Protocol

Timeline of Effects

Biomarkers to Monitor

How It Works

Thymosin Alpha-1 (TA-1) is a natural thymic peptide that modulates innate and adaptive immunity — increasing NK cell activity, upregulating T-helper cell function, and normalising cytokine balance. It does not overstimulate but rather recalibrates dysregulated immune responses. BPC-157 provides the tissue repair component, while also acting on the gut-brain axis to reduce systemic inflammation. Together they address the root cause of poor recovery: immune dysfunction plus unresolved tissue damage. This combination is particularly valuable for those with post-viral fatigue, autoimmune tendencies, or chronic inflammatory states.

Research Protocol

Timeline of Effects

Biomarkers to Monitor

Why Pulsatile GH Matters

Natural growth hormone is released in discrete pulses — primarily during slow-wave sleep. This pulsatility is essential: continuous GH elevation (as seen with exogenous HGH) desensitises receptors and disrupts glucose metabolism. Ipamorelin is a selective GH secretagogue (GHRP) — it triggers a clean GH pulse with minimal effect on cortisol or prolactin. CJC-1295 no-DAC (Modified GRF 1-29) extends the GHRH window, amplifying the pulse. Together they mimic the natural GH release architecture — dramatically more physiological than synthetic HGH.

Research Protocol

Timeline of Effects

Biomarkers to Monitor

How It Works

Sermorelin is a 29-amino acid analogue of endogenous GHRH — the most "natural" GH stimulator available. Unlike CJC-1295 no-DAC (which has stronger pulse amplitude), Sermorelin produces a more physiological GH release pattern. Combined with Ipamorelin (which adds a complementary GHRP signal), this creates an ideal dual-mechanism stack for subjects aged 40+ who want GH restoration without the risk of overshooting physiological ranges. The self-regulating nature of Sermorelin (it cannot produce GH above what the pituitary can release) makes it particularly safe for longer protocols.

Research Protocol

Timeline of Effects

Biomarkers to Monitor

How It Works

CJC-1295 with DAC (Drug Affinity Complex) binds albumin in the bloodstream, extending its half-life to 6–8 days. A single 2mg weekly injection maintains elevated GHRH signalling throughout the week — producing consistent, blunted (rather than pulsatile) GH elevation. This is combined with daily or 3× weekly Ipamorelin injections to add pulsatile peaks on top of the steady GHRH background. Note: the blunted profile may not be ideal for glucose-sensitive subjects — monitor fasting glucose closely. Best suited to experienced researchers who have completed a no-DAC cycle first.

Research Protocol

Biomarkers to Monitor

How It Works

Epitalon (Epithalon) is a tetrapeptide developed by Prof. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation. It activates telomerase — the enzyme responsible for rebuilding telomere length. In human research, Epitalon has been shown to reduce circadian rhythm disorders, normalise melatonin production, and extend the maximum lifespan of cells in culture. Pinealon is a tri-peptide (EDR) that penetrates the blood-brain barrier and acts directly on pineal gland function — restoring neurotransmitter synthesis and circadian gene expression. DSIP (Delta Sleep-Inducing Peptide) enhances slow-wave sleep architecture, the period when GH is released and cellular repair is maximised. Together, these three compounds create a comprehensive circadian and longevity reset.

Research Protocol

Timeline of Effects

Biomarkers to Monitor

How It Works

MOTS-c and Humanin are both mitochondria-derived peptides (MDPs) — encoded within the mitochondrial genome itself, not the nuclear genome. MOTS-c activates AMPK (the master metabolic sensor), enhances insulin sensitivity, promotes glucose uptake independent of insulin, and triggers mitophagy (clearance of damaged mitochondria). Humanin acts as a cytoprotective factor — it crosses the blood-brain barrier, protects neurons from amyloid toxicity, reduces oxidative stress, and inhibits apoptosis in metabolically stressed cells. Circulating levels of both peptides decline with age, making supplementation a logical longevity strategy.

Research Protocol

Biomarkers to Monitor

How It Works

P21 is a synthetic analogue of CNTF (Ciliary Neurotrophic Factor) — it penetrates the blood-brain barrier to promote neuroplasticity, neurogenesis, and neuroprotection. It activates STAT3 signalling pathways, increases BDNF expression, and has shown potential in reducing amyloid accumulation in early neurodegeneration models. Combined with MOTS-c (which improves the metabolic substrate available to neurons by enhancing mitochondrial efficiency and glucose uptake), this creates a comprehensive brain health + longevity protocol. P21 requires light-protected storage and careful handling — not recommended for first-time researchers.

Research Protocol

Biomarkers to Monitor

How It Works

Thymosin Alpha-1 is a 28-amino acid peptide naturally secreted by the thymus gland. It is clinically used in over 35 countries for chronic hepatitis, cancer support, and immune deficiency. It works by increasing the maturation and differentiation of T-cells, enhancing dendritic cell function, upregulating NK cell cytotoxicity, and modulating the Th1/Th2 balance — moving chronically dysregulated immune systems back toward homeostasis. Unlike general "immune boosters", TA-1 is bidirectional: it calms overactive immune responses (autoimmunity, allergies) while stimulating underactive ones (poor infection response, post-viral fatigue).

Research Protocol

Biomarkers to Monitor

How It Works

VIP (Vasoactive Intestinal Peptide) is a neuropeptide with profound anti-inflammatory and immunomodulatory effects. It inhibits TNF-α, IL-6, and IL-12 production by macrophages while upregulating regulatory T-cells. In MCAS (Mast Cell Activation Syndrome), VIP is particularly effective at stabilising mast cell degranulation. It also acts as a bronchodilator, reduces LPS-induced systemic inflammation, and has neuroprotective properties via VIP receptors in the CNS. Cold chain critical: VIP is extremely fragile and degrades rapidly at room temperature. Requires constant refrigeration at 4°C from manufacturer to use. Not recommended for first-time researchers.

Research Protocol

Biomarkers to Monitor

Triple Agonist Mechanism

Retatrutide activates three distinct metabolic hormone receptors simultaneously: GLP-1 (glucagon-like peptide-1) — reduces appetite, slows gastric emptying, improves insulin sensitivity; GIP (glucose-dependent insulinotropic polypeptide) — enhances insulin secretion and adipocyte function; Glucagon receptor — uniquely increases energy expenditure and hepatic fat oxidation, preventing the metabolic adaptation that limits other GLP-1 agents. Phase 2 clinical data showed 24% body weight reduction at 48 weeks — significantly exceeding tirzepatide and semaglutide results. Weekly injection protocol.

Titration Protocol

Timeline of Effects

Biomarkers to Monitor

How It Works

AOD-9604 is the C-terminal fragment of human growth hormone (hGH176-191) — the specific region responsible for GH's fat-burning activity, without the growth-promoting or insulin-desensitising effects of full HGH. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat creation) by acting on adipocyte receptors. Unlike full HGH, it does not raise IGF-1 or affect glucose metabolism. Administered daily in the fasted state to maximise lipolytic window. Best combined with a caloric deficit or fasted cardio protocol for synergistic fat loss.

Research Protocol

Biomarkers to Monitor

How It Works

Tesamorelin is a modified analogue of endogenous GHRH that has FDA approval for HIV-associated lipodystrophy (visceral fat accumulation). Daily dosing produces sustained GH pulsatility that specifically targets visceral adipose tissue — the metabolically dangerous intra-abdominal fat associated with cardiovascular risk and insulin resistance. Multiple RCTs demonstrate significant reductions in visceral fat area (VAT) as measured by CT scan. IGF-1 rises modestly. Unlike GLP-1 agents, it works through a completely different mechanism and can be combined with other protocols.

Research Protocol

Biomarkers to Monitor

How It Works

Semax is a synthetic analogue of ACTH 4-7 developed by the Russian Academy of Sciences. It increases BDNF (brain-derived neurotrophic factor), upregulates dopaminergic and serotonergic transmission, and provides neuroprotection. Users typically experience increased focus, mental clarity, verbal fluency, and motivation. Selank is an anxiolytic neuropeptide that modulates GABA-A receptor function without the tolerance/dependence issues of benzodiazepines. It also increases BDNF and has shown antidepressant properties. Together they balance stimulatory cognitive effects (Semax) with anxiolytic stability (Selank) — creating focused calm rather than anxious drive. Both are administered intranasally, typically as prepared nasal sprays.

Nasal Spray Preparation

Dissolve lyophilised peptide in bacteriostatic water (0.9% sodium chloride or BAC water). Target concentration: 1mg/ml. Load into sterile nasal spray bottle. Store refrigerated. Each spray delivers approximately 100mcg. Typical protocol: 2–3 sprays per nostril, alternating. Note: intranasal administration produces rapid onset (15–30 min) but shorter duration than injection.

Research Protocol

Biomarkers to Monitor

How It Works

P21 is a 22-amino acid synthetic analogue of CNTF (Ciliary Neurotrophic Factor). It penetrates the blood-brain barrier and activates STAT3 signalling — increasing BDNF expression, promoting neurogenesis in the hippocampus, and providing neuroprotection against amyloid-beta toxicity. Early animal research has shown significant improvements in spatial memory and cognitive flexibility. Requires light-protected storage — even brief light exposure degrades the peptide. Always handle in amber vials or wrapped in foil.

Research Protocol

Biomarkers to Monitor

How It Works

DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide that increases the proportion of slow-wave (delta) sleep — the most restorative sleep stage. Delta sleep is when growth hormone pulsatility peaks, cellular repair occurs, and memory consolidation takes place. DSIP does not cause sedation like pharmaceutical sleep aids — instead it shifts the sleep architecture toward deeper, more restorative cycles. It also modulates LH, GH and cortisol rhythms, and has shown antioxidant and neuroprotective properties. Typically used as part of a longevity protocol or to restore circadian rhythm after disruption.

Research Protocol

Biomarkers to Monitor